Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Expanded Access Study for Renal Transplant Patients With Envarsus XR ™
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Human Penile Allotransplantation
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE4
To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks
- Status
- TERMINATED
- Phase
- N/A
A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)
- Status
- COMPLETED
- Phase
- PHASE3
Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major
- Status
- COMPLETED
- Phase
- PHASE4
Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant Patients
- Status
- UNKNOWN
- Phase
- NA
Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
- Status
- COMPLETED
- Phase
- PHASE3
Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant
- Status
- SUSPENDED
- Phase
- PHASE1
Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
- Status
- COMPLETED
- Phase
- PHASE2
JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Belatacept 3 Month Post Transplant Conversion Study
- Status
- COMPLETED
- Phase
- PHASE4